Avalyn Pharma Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| FMR LLC | 08/13/2026 | 5.84 M | $192.10 M | 100.00% | 13.16% |
| NOVO HOLDINGS A/S | 08/14/2026 | 3.88 M | $127.84 M | 100.00% | 8.76% |
| SR ONE CAPITAL MANAGEMENT, LP | 08/12/2026 | 3.31 M | $108.92 M | 100.00% | 7.46% |
| PERCEPTIVE ADVISORS LLC | 08/14/2026 | 2.68 M | $88.07 M | 100.00% | 6.03% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 08/14/2026 | 2.50 M | $82.40 M | 100.00% | 5.65% |
| NVP ASSOCIATES, LLC | 08/07/2026 | 2.27 M | $74.68 M | 100.00% | 5.12% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2026 | 2.20 M | $72.49 M | 100.00% | 4.97% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2026 | 1.74 M | $57.12 M | 100.00% | 3.91% |
| CATALIO CAPITAL MANAGEMENT, LP | 08/14/2026 | 1.68 M | $55.17 M | 100.00% | 3.78% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2026 | 1.60 M | $52.76 M | 100.00% | 3.62% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/14/2026 | 1.38 M | $45.28 M | 100.00% | 3.10% |
| BELLEVUE GROUP AG | 08/14/2026 | 1.35 M | $44.44 M | 100.00% | 3.05% |
| BLACKROCK, INC. | 08/07/2026 | 977.26 K | $32.17 M | 100.00% | 2.20% |
| PIVOTAL BIOVENTURE PARTNERS INVESTMENT ADVISOR LLC | 08/13/2026 | 966.79 K | $31.83 M | 100.00% | 2.18% |
| CITADEL ADVISORS LLC | 09/02/2026 | 959.10 K | $31.57 M | 100.00% | 2.16% |
| ANDERA PARTNERS | 07/22/2026 | 929.82 K | $30.61 M | 100.00% | 2.10% |
| JENNISON ASSOCIATES LLC | 08/03/2026 | 812.75 K | $26.76 M | 100.00% | 1.83% |
| BRAIDWELL LP | 08/14/2026 | 801.40 K | $26.38 M | 100.00% | 1.81% |
| TPG GP A, LLC | 08/14/2026 | 773.07 K | $25.45 M | 100.00% | 1.74% |
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 739.77 K | $24.35 M | 100.00% | 1.67% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 08/14/2026 | 731.00 K | $24.06 M | 100.00% | 1.65% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 08/14/2026 | 662.92 K | $21.82 M | 100.00% | 1.50% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 434.65 K | $14.31 M | 100.00% | 0.98% |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 08/11/2026 | 419.00 K | $13.79 M | 100.00% | 0.95% |
| INFINITUM ASSET MANAGEMENT, LLC | 08/14/2026 | 411.38 K | $13.54 M | 100.00% | 0.93% |
| BAKER BROS. ADVISORS LP | 08/14/2026 | 350.00 K | $11.52 M | 100.00% | 0.79% |
| FRANKLIN RESOURCES INC | 08/13/2026 | 331.68 K | $10.92 M | 100.00% | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 08/13/2026 | 330.49 K | $10.88 M | 100.00% | 0.75% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 283.85 K | $9.34 M | 100.00% | 0.64% |
| FEDERATED HERMES, INC. | 08/12/2026 | 160.00 K | $5.27 M | 100.00% | 0.36% |
| WOODLINE PARTNERS LP | 08/14/2026 | 151.00 K | $4.97 M | 100.00% | 0.34% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/14/2026 | 146.99 K | $4.84 M | 100.00% | 0.33% |
| SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. | 08/14/2026 | 146.99 K | $4.84 M | 100.00% | 0.33% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 08/14/2026 | 146.45 K | $4.82 M | 100.00% | 0.33% |
| NORTHERN TRUST CORP | 08/13/2026 | 136.39 K | $4.49 M | 100.00% | 0.31% |
| STEMPOINT CAPITAL LP | 08/14/2026 | 118.00 K | $3.88 M | 100.00% | 0.27% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 08/13/2026 | 117.34 K | $3.86 M | 100.00% | 0.26% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 116.76 K | $3.84 M | 100.00% | 0.26% |
| ACUTA CAPITAL PARTNERS, LLC | 08/14/2026 | 115.00 K | $3.79 M | 100.00% | 0.26% |
| BURKEHILL GLOBAL MANAGEMENT, LP | 08/14/2026 | 115.00 K | $3.79 M | 100.00% | 0.26% |
| MOORE CAPITAL MANAGEMENT, LP | 08/14/2026 | 110.45 K | $3.64 M | 100.00% | 0.25% |
| BLACKSTONE INC. | 08/14/2026 | 97.99 K | $3.23 M | 100.00% | 0.22% |
| TD ASSET MANAGEMENT INC | 08/04/2026 | 94.64 K | $3.12 M | 100.00% | 0.21% |
| SEVEN GRAND MANAGERS, LLC | 08/14/2026 | 75.00 K | $2.47 M | 100.00% | 0.17% |
| GHISALLO CAPITAL MANAGEMENT LLC | 08/14/2026 | 70.00 K | $2.30 M | 100.00% | 0.16% |
| ATOM INVESTORS LP | 08/14/2026 | 68.25 K | $2.25 M | 100.00% | 0.15% |
| ABRDN PLC | 07/31/2026 | 67.17 K | $2.21 M | 100.00% | 0.15% |
| ZIMMER PARTNERS, LP | 08/14/2026 | 62.50 K | $2.06 M | 100.00% | 0.14% |
| AVIDITY PARTNERS MANAGEMENT LP | 08/14/2026 | 60.00 K | $1.98 M | 100.00% | 0.14% |
| LMR PARTNERS LLP | 08/14/2026 | 54.32 K | $1.79 M | 100.00% | 0.12% |
Avalyn Pharma Inc. institutional Ownership - FAQ's
During the previous two years, 94 institutional investors and hedge funds held shares of Avalyn Pharma Inc.. The most heavily invested institutionals were:
FMR LLC: 5.84 M
Novo Holdings A/S: 3.88 M
SR ONE CAPITAL MANAGEMENT, LP: 3.31 M
PERCEPTIVE ADVISORS LLC: 2.68 M
SUVRETTA CAPITAL MANAGEMENT, LLC: 2.5 M
NVP Associates, LLC: 2.27 M
99.60% of Avalyn Pharma Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 44.15 M shares in the last 24 months. This purchase volume represents approximately $0 in transactions.